Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • Nora AI
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Elos Medtech AB: Elos Medtech Interim Report January 1 - March 31, 2023

Elos Medtech
Download the release
January - March 2023
  • Net sales for the first quarter amounted to SEK 267.2 (194.5) million, an increase of 37.4 percent compared to the same quarter last year. Net sales in local currencies increased by 29.5 percent.
  • Operating profit amounted to SEK 44.4 (29.2) million, corresponding to an operating margin of 16.6 (15.0) percent.
  • Profit after net financial items amounted to SEK 30.8 (29.8) million. Net financial items were negatively affected by exchange rate differences of SEK -4.7 (0.8) million and totaled SEK -13.6 (0.6) million.
  • Cash flow from operating activities was SEK 13.1 (8.3) million, and SEK -17.8 (-20.0) million after investments.
  • Earnings per share amounted to SEK 2.91 (2.85).
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.